申请人:Garcia Gabriel
公开号:US20050070570A1
公开(公告)日:2005-03-31
The invention relates to compounds having the Formula (I) or a salt, or a physiologically functional derivative, or a prodrug thereof,
wherein Z is carbonyl or sulfonyl;
R
1
is alkyl, alkenyl, alkynyl, aryl, H, halogen, haloalkyl, haloalkoxy, hydroxyalkyl, cycloalkyl or heteroaryl;
R
2
is H, OH, —CH
2
—SO
2
-alkyl, —CH
2
—SO
2
-cycloalkyl, —CH
2
—SO
2
-aryl, —CH
2
—SO
2
-heteroaryl, alkylamine, alkenylamine, alkynylamine, cycloalkylamine, arylamine, heteroarylamine, aryl, haloalkyl, haloalkoxy, hydroxyalkyl, cycloalkyl, heteroaryl or a linear or branched alkyl, alkenyl, alkynyl, which can optionally be substituted by one or more substituents R
3
;
R
3
is H, alkyl, alkenyl, alkynyl, cycloalkyl, —CO
2
R
4
, —CONHR
4
, —CONR
4
R
4
, —CR
4
O, —SO
2
R
4
, —NR
4
—CO—R
4
, alkoxy, alkylthio, —OH, —SH, —O-aryl, —O-cycloalkyl, —S-aryl, —S-cycloalkyl, hydroxyalkyl, halogen, haloalkyl, haloalkoxy, CN, NO
2
, hydroxyalkylamine, aminoalkyl, alkylamine, aryl or heteroaryl;
R
4
is H, halogen, alkyl, alkenyl, alkynyl, cycloalkyl, alkoxy, alkylthio, —O-aryl, —O-cycloalkyl, OH, SH, —S-aryl, —S-cycloalkyl, hydroxyalkyl, haloalkyl, haloalkoxy, hydroxyalkyl-amine, aminoalkyl, alkylamine, aryl or heteroaryl;
R
5
is alkyl, alkenyl or alkynyl.
该发明涉及具有式(I)的化合物或其盐,或其生理功能衍
生物,或其前药,其中Z为羰基或磺酰基;R1为烷基,
烯烃基,
炔烃基,芳基,
氢,卤素,卤代烷基,卤代甲
氧基,羟基烷基,
环烷基或杂环芳基;R2为
氢,羟基,—
CH2—SO2-烷基,— —SO2-
环烷基,— —SO2-芳基,— —SO2-杂环芳基,烷基胺,
烯烃基胺,
炔烃基胺,
环烷基胺,芳基胺,杂环芳基胺,芳基,卤代烷基,卤代甲
氧基,羟基烷基,
环烷基,杂环芳基或一个线性或支链烷基,
烯烃基,
炔烃基,可以选择地被一个或多个取代基R3取代;R3为
氢,烷基,
烯烃基,
炔烃基,
环烷基,—CO2R4,—CONHR4,—CONR4R4,—CR4O,—SO2R4,—NR4—CO—R4,烷
氧基,烷基
硫醚,—羟基,—
硫氢,—O-芳基,—O-
环烷基,—S-芳基,—S-
环烷基,羟基烷基,卤素,卤代烷基,卤代甲
氧基,CN,
NO2,羟基烷胺,
氨基烷基,烷基胺,芳基或杂环芳基;R4为
氢,卤素,烷基,
烯烃基,
炔烃基,
环烷基,烷
氧基,烷基
硫醚,—O-芳基,—O-
环烷基,羟基,
硫氢,—S-芳基,—S-
环烷基,羟基烷基,卤代烷基,卤代甲
氧基,羟基烷胺,
氨基烷基,烷基胺,芳基或杂环芳基;R5为烷基,
烯烃基或
炔烃基。